Parallel-Group Controlled Trial of Surgery Versus Chemoradiotherapy in Patients With Stage I Esophageal Squamous Cell Carcinoma
Ken Kato(National Cancer Center Hospital East), Yuko Kitagawa(Keio University), Masahiko Yano(Nagoya Sangyo University), Tetsuya Abe(Aichi Cancer Center), Shigeru Tsunoda(Kyoto University), Yasushi Toh(National Hospital Organization Kyushu Cancer Center), Seiichiro Yamamoto(National Cancer Centre Japan), Satoru Nakagawa(Apple (Israel)), Takashi Kojima(National Cancer Center Hospital East), Isao Nozaki(National Hospital Organization), Hiroyuki Daiko(Juntendo University), Yoshinori Ito(National Cancer Center Hospital East), Kenichi Nakamura(Japan Clinical Cancer Research Organization), Yuichi Shibuya(University of Kochi), Masaki Ueno(Toranomon Hospital), Morihito Okada(Hiroshima University), Tetsu Nakamura, Masakazu Takagi(Apple (Israel)), Hiroshi Katayama(National Cancer Center)
Cited by 119
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
|The Lancet|2022|1.6k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2011|713